BioNexus Gene Lab Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioNexus Gene Lab Corp. generated cash of -$1,301,595, which is less than the previous year. Cash used in financing activities reached the amount of $5,754,322 last year. Net change in cash is therefore $3,810,472.
Cash Flow
| 2016 | -835 | 0 | 638 |
|---|---|---|---|
| 2017 | 357.21K | -5.31M | 5.78M |
| 2018 | -274.08K | -51.70K | 742.94K |
| 2019 | -217.27K | -12.81K | -180.80K |
| 2020 | 552.68K | 1.31M | -4.94K |
| 2021 | 9.16K | -490.57K | -28.22K |
| 2022 | 544.02K | -450.49K | 115.96K |
| 2023 | -1.30M | -382.57K | 5.75M |
BGLC Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.11M | 2.12M | 2.78M | 859.07K | 1.26M | 839.14K | 26 | 134 |
Operating activities | ||||||||
Net income | -2.62M | -355.96K | 751.57K | 1.09M | -246.46K | 26.45K | -123.75K | -835 |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 108.42K | 105.41K | 108.21K | 101.60K | 53.33K | 40.61K | 15.03K | 0 |
Stock-based compensation expense | 511.74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 511.74K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 650.81K | 538.64K | 579.21K | 411.06K | 9.75K | 105.67K | -6.48K | 0 |
Inventories | -160.38K | 544.10K | -345.74K | 147.03K | 7.72K | 16.78K | -32.08K | 0 |
Accounts payable | -349.32K | -119.69K | -1.13M | -524.24K | -30.60K | -463.60K | 477.88K | 0 |
Cash generated by operating activities | -1.30M | 544.02K | 9.16K | 552.68K | -217.27K | -274.08K | 357.21K | -835 |
Investing activities | ||||||||
Purchases Of Investments | -320.73K | -511.70K | -515.84K | -108.63K | 0 | -12.08K | 0 | 0 |
Investments In Property Plant And Equipment | -149.39K | -54.17K | -3.16K | -421.62K | -12.81K | -39.62K | -314.82K | 0 |
Acquisitions Net | 0 | 0 | 0 | 346.00K | 0 | 0 | -5M | 0 |
Cash generated by investing activities | -382.57K | -450.49K | -490.57K | 1.31M | -12.81K | -51.70K | -5.31M | 0 |
Financing activities | ||||||||
Common Stock Issued | 5.75M | 150K | 0 | 0 | 0 | 741.5K | 5.20M | 0 |
Payments for dividends | 0 | -115.37K | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -34.03K | -26.30K | -4.94K | -16.77K | 0 | 0 | 0 |
Cash used in financing activities | 5.75M | 115.96K | -28.22K | -4.94K | -180.80K | 742.94K | 5.78M | 638 |
Net Change In Cash | 3.81M | -5.05K | -663.77K | 1.92M | -401.16K | 421.09K | 839.11K | -108 |
Cash at end of period | 5.92M | 2.11M | 2.12M | 2.78M | 859.07K | 1.26M | 839.14K | 26 |
| Data source | Data source | Data source | Data source | Data source |